A new methodology for predicting human pharmacokinetics for inhaled drugs from oratracheal pharmacokinetic data in rats

References

• Anjilvel S, Asgharian B. (1995). A multiple-path model of particle deposition in the rat lung. Fundam Appl Toxicol 28:41–50.
   PubMedGoogle Scholar
• Banker MJ, Clark TH, Williams JA. (2003). Development and validation of a 96-well equilibrium dialysis apparatus for measuring plasma protein binding. J Pharm Sci 92:967–974.
   PubMed Web of Science ®Google Scholar
• Bennett JA, Harrison TW, Tattersfield AE. (1999). The contribution of the swallowed fraction of an inhaled dose of salmeterol to it systemic effects. Eur Respir J 13:445–448.
   PubMed Web of Science ®Google Scholar
• Biddescombe MF, Melchor R, Mak VHF, Marriott RJ, Taylor AJ, Short MD and Spiro SG. (1993). The lung deposition of salbutamol, directly labeled with technetium-99m, delivered by pressurized metered dose and dry powder inhalers. Int J Pharm 91:111–121.
   Google Scholar
• Boddy A, Edwards P, Rowland M. (1989). Binding of sulfonamides to carbonic anhydrase: influence on distribution within blood and on pharmacokinetics. Pharm Res 6:203–209.
   PubMedGoogle Scholar
• Borgström L, Olsson B, Thorsson L. (2006). Degree of throat deposition can explain the variability in lung deposition of inhaled drugs. J Aerosol Med 19:473–483.
   PubMedGoogle Scholar
• Brindley C, Falcoz C, Mackie AE, Bye A. (2000). Absorption kinetics after inhalation of fluticasone propionate via the Diskhaler, Diskus and metered-dose inhaler in healthy volunteers. Clin Pharmacokinet 39:1–8.
   PubMedGoogle Scholar
• Byron P. (1990). Respiratory Drug Delivery. CRC press P113.
   Google Scholar
• Clark DJ, Lipworth BJ. (1996). Lung bioavailability of chlorofluorocarbon free, dry powder and chlorofluorocarbon containing formulations of salbutamol. Br J Clin Pharmacol 41:247–249.
   PubMedGoogle Scholar
• Crapo JD, Young SL, Fram EK, Pinkerton KE, Barry BE, Crapo RO. (1983). Morphometric characteristics of cells in the alveolar region of mammalian lungs. Am Rev Respir Dis 128:42–46.
   PubMed Web of Science ®Google Scholar
• Crompton GK. (1991). Dry powder inhalers: Advantages and limitations. J Aerosol Med 4:151–156.
   PubMedGoogle Scholar
• Davies B, Morris T. (1993). Physiological parameters in laboratory animals and humans. Pharm Res 10:1093–1095.
   PubMed Web of Science ®Google Scholar
• De Buck SS, Sinha VK, Fenu LA, Nijsen MJ, Mackie CE, Gilissen RA. (2007). Prediction of human pharmacokinetics using physiologically based modeling: A retrospective analysis of 26 clinically tested drugs. Drug Metab Dispos 35:1766–1780.
   PubMed Web of Science ®Google Scholar
• DeSesso JM, Williams AC. (2008). Contrasting the gastrointestinal tracts of mammals: Factors that influence absorption. Annual reports in medicinal chemistry, published by elsevier science & technology 43:353–371
   Web of Science ®Google Scholar
• Edsbäcker S, Johansson CJ. (2006). Airway selectivity: An update of pharmacokinetic factors affecting local and systemic disposition of inhaled steroids. Basic Clin Pharmacol Toxicol 98:523–536.
   PubMed Web of Science ®Google Scholar
• Gabrielson J, Weiner D. (2000). Pharmacokinetic and pharmacodynamic data analysis: Concepts and applications. Stockholm, Sweden: Swedish Pharmaceutical Press. pp. 163–164.
   Google Scholar
• Gehr P, Mwangi DK, Ammann A, Maloiy GM, Taylor CR, Weibel ER. (1981). Design of the mammalian respiratory system. V. Scaling morphometric pulmonary diffusing capacity to body mass: Wild and domestic mammals. Respir Physiol 44:61–86.
   PubMedGoogle Scholar
• Hosea NA, Collard WT, Cole S, Maurer TS, Fang RX, Jones H, Kakar SM, Nakai Y, Smith BJ, Webster R, Beaumont K. (2009). Prediction of human pharmacokinetics from preclinical information: Comparative accuracy of quantitative prediction approaches. J Clin Pharmacol 49:513–533.
   PubMed Web of Science ®Google Scholar
• Kastl S, Kotschenreuther U, Hille B, Schmidt J, Gepp H, Hohenberger W. (2004). Simplification of rat intubation on inclined metal plate. Adv Physiol Educ 28:29–32.
   PubMedGoogle Scholar
• Kwon Y. (2001). Handbook of essential pharmacokinetics, pharmacodynamics and drug metabolism for industrial scientists. New York: Kluwer academic/plenum publishers.
   Google Scholar
• Lahelma S, Kirjavainen M, Kela M, Herttuainen J, Vahteristo M, Silvasti M, Ranki-Pesonen M. (2004). Equivalent lung deposition of budesonide in vivo: A comparison of dry powder inhalers using a pharmacokinetic method. Br J Clin Pharmacol 59:167–173.
   Web of Science ®Google Scholar
• Lave T, Dupin S, Schmitt C, Chou RC, Jaeck D, Coassolo P. (2000). Integration of in vitro data into allometric scaling to predict hepatic metabolic clearance in man: Application to 10 extensively metabolized drugs. J Pharm Pharmaceut Sci 86:584–590.
   Google Scholar
• Lecaillon JB, Kaiser G, Palmisano M, Morgan J, Della Cioppa G. (1999). Pharmacokinetics and tolerability of formoterol in healthy volunteers after a single high dose of Foradil dry powder inhalation via Aerolizer. Eur J Clin Pharmacol 55:131–138.
   PubMed Web of Science ®Google Scholar
• Lipworth BJ, Clark DJ. (1997). Comparative lung delivery of salbutamol given via Turbuhaler and Diskus dry powder inhaler devices. Eur J Clin Pharmacol 53:47–49.
   PubMedGoogle Scholar
• Manchee GR, Barrow A, Kulkarni S, Palmer E, Oxford J, Colthup PV, Maconochie JG, Tarbit MH. (1993). Disposition of salmeterol xinafoate in laboratory animals and humans. Drug Metab Dispos 21:1022–1028.
   PubMedGoogle Scholar
• Mantell S, Jones RM, Trevethick M. (2010). Design and application of locally delivered agonists of the adenosine A2A receptor. Expet Rev Clin Pharmacol 3:55–72.
   PubMedGoogle Scholar
• Meyer T, Brand P, Ehlich H, Köbrich R, Meyer G, Riedinger F, Sommerer K, Weuthen T, Scheuch G. (2004). Deposition of Foradil P in human lungs: Comparison of in vitro and in vivo data. J Aerosol Med 17:43–49.
   PubMedGoogle Scholar
• McGinnity DF, Collington J, Austin RP, Riley RJ. (2007). Evaluation of human pharmacokinetics, therapeutic dose and exposure predictions using marketed oral drugs. Curr Drug Metab 8:463–479.
   PubMed Web of Science ®Google Scholar
• Patton JS, Fishburn CS, Weers JG. (2004). The lungs as a portal of entry for systemic drug delivery. Proc Am Thorac Soc 1:338–344.
   PubMedGoogle Scholar
• Plopper CG. (1983). Comparative morphologic features of bronchiolar epithelial cells. The Clara cell. Am Rev Respir Dis 128:37–41.
   PubMed Web of Science ®Google Scholar
• Schanker LS, Less MJ. (1977). Lung pH and pulmonary absorption of nonvolatile drugs in the rat. Drug Metab Dispos 5:174–178.
   PubMed Web of Science ®Google Scholar
• Schanker LS, Mitchell EW, Brown RA Jr. (1986). Species comparison of drug absorption from the lung after aerosol inhalation or intratracheal injection. Drug Metab Dispos 14:79–88.
   PubMed Web of Science ®Google Scholar
• Sinha VK, De Buck SS, Fenu LA, Smit JW, Nijsen M, Gilissen RA, Van Peer A, Lavrijsen K, Mackie CE. (2008). Predicting oral clearance in humans: How close can we get with allometry? Clin Pharmacokinet 47:35–45.
   PubMed Web of Science ®Google Scholar
• Smith JH, Williams H. (2006). Introduction to the principles of drug design and action. Florida, USA, CRC press: Taylor & Francis group P68.
   Google Scholar
• Tang H, Mayersohn M. (2005). A novel model for prediction of human drug clearance by allometric scaling. Drug Metab Dispos 33:1297–1303.
   PubMed Web of Science ®Google Scholar
• Tayab ZR, Hochhaus G. (2005). Pharmacokinetic/pharmacodynamic evaluation of inhalation drugs: Application to targeted pulmonary delivery systems. Expert Opin Drug Deliv 2:519–532.
   PubMedGoogle Scholar
• Thorsson L, Edsbäcker S, Conradson TB. (1994). Lung deposition of budesonide from Turbuhaler is twice that from a pressurized metered-dose inhaler P-MDI. Eur Respir J 7:1839–1844.
   PubMed Web of Science ®Google Scholar
• Thorsson L, Edsbäcker S, Källén A, Löfdahl CG. (2001). Pharmacokinetics and systemic activity of fluticasone via Diskus and pMDI, and of budesonide via Turbuhaler. Br J Clin Pharmacol 52:529–538.
   PubMed Web of Science ®Google Scholar
• Tronde A, Nordén B, Jeppsson AB, Brunmark P, Nilsson E, Lennernäs H, Bengtsson UH. (2003). Drug absorption from the isolated perfused rat lung–correlations with drug physicochemical properties and epithelial permeability. J Drug Target 11:61–74.
   PubMed Web of Science ®Google Scholar
• van den Berg BT, Braat MC, van Boxtel CJ. (1998). Pharmacokinetics and effects of formoterol fumarate in healthy human subjects after oral dosing. Eur J Clin Pharmacol 54:463–468.
   PubMedGoogle Scholar
• Ward JK, Dow J, Dallow N, Eynott P, Milleri S, Ventresca GP. (2000). Enantiomeric disposition of inhaled, intravenous and oral racemic-salbutamol in man–no evidence of enantioselective lung metabolism. Br J Clin Pharmacol 49:15–22.
   PubMed Web of Science ®Google Scholar
• Warheit DB. (1989). Interspecies comparisons of lung responses to inhaled particles and gases. Crit Rev Toxicol 20:1–29.
   PubMed Web of Science ®Google Scholar
• Winkler J, Hochhaus G, Derendorf H. (2004). How the lung handles drugs: pharmacokinetics and pharmacodynamics of inhaled corticosteroids. Proc Am Thorac Soc 1:356–363.
   PubMedGoogle Scholar